Expertise in
9
conditions

Dr. Jeffrey Sager

Intensive Care Medicine
Lompoc Satellite Ofice
136 N 3rd St, 
Lompoc, CA 
Offers Telehealth
Expertise in
9
conditions
Lompoc Satellite Ofice
136 N 3rd St, 
Lompoc, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Sager is an Intensive Care Medicine provider in Lompoc, California. Dr. Sager is highly rated in 9 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Bronchiectasis, Pleural Effusion, Lung Metastases, and Endoscopy.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in CA
Hospital Affiliations
Santa Barbara Cottage Hospital
Santa Ynez Valley Cottage Hospital
Lompoc Valley Medical Center
Goleta Valley Cottage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Lompoc Satellite Ofice
136 N 3rd St, Lompoc, CA 93436
Call: 805-845-1500
Other Locations
Jeffrey S Sager MD Medical Corporation
2428 Castillo St Ste D, Santa Barbara, CA 93105
Call: 805-845-1500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

20 Total Publications

Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
Journal: Annals of the American Thoracic Society
Published: February 18, 2025
View All 20 Publications
Similar Doctors
Expertise in
5
conditions
Dr. Gabriel Z. Reagle
Intensive Care Medicine | Pulmonary Medicine
Expertise in
5
conditions
Dr. Gabriel Z. Reagle
Intensive Care Medicine | Pulmonary Medicine

Pacific Coast Critical Care

1400 E Church St, 
Santa Maria, CA 
 (53.1 miles away)
559-260-2600
Experience:
18+ years
Languages Spoken:
English
See accepted insurances

Gabriel Reagle is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Santa Maria, California. Dr. Reagle has been practicing medicine for over 18 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Advanced Bronchoscopy.

Expertise in
6
conditions
Dr. Barry S. Feldman
Intensive Care Medicine | Pulmonary Medicine | Sleep Medicine
Expertise in
6
conditions
Dr. Barry S. Feldman
Intensive Care Medicine | Pulmonary Medicine | Sleep Medicine
670 Southridge Ln, 
Nipomo, CA 
 (62.5 miles away)
805-363-2331
Languages Spoken:
English
See accepted insurances

Barry Feldman is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Nipomo, California. Dr. Feldman is highly rated in 6 conditions, according to our data. His top areas of expertise are Asthma, Asthma in Children, Grass Allergy, Obstructive Sleep Apnea, and Gastrostomy.

Expertise in
5
conditions
Dr. Jeffrey Kupperman
Intensive Care Medicine
Expertise in
5
conditions
Dr. Jeffrey Kupperman
Intensive Care Medicine

Jeffrey L. Kupperman, M.D.

2428 Castillo St Ste D, 
Santa Barbara, CA 
 (8.0 miles away)
805-845-1500
Languages Spoken:
English
See accepted insurances

Jeffrey Kupperman is an Intensive Care Medicine provider in Santa Barbara, California. Dr. Kupperman is highly rated in 5 conditions, according to our data. His top areas of expertise are Bronchiectasis, Lung Metastases, Chronic Cough, and Chronic Obstructive Pulmonary Disease (COPD).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sager's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Sager is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
    • Advanced
    • Bronchiectasis
      Dr. Sager is
      Advanced
      . Learn about Bronchiectasis.
      See more Bronchiectasis experts
    • Chronic Cough
      Dr. Sager is
      Advanced
      . Learn about Chronic Cough.
      See more Chronic Cough experts
    • Chronic Obstructive Pulmonary Disease (COPD)
      Dr. Sager is
      Advanced
      . Learn about Chronic Obstructive Pulmonary Disease (COPD).
      See more Chronic Obstructive Pulmonary Disease (COPD) experts
    • Lung Metastases
      Dr. Sager is
      Advanced
      . Learn about Lung Metastases.
      See more Lung Metastases experts
    • Lung Nodules
      Dr. Sager is
      Advanced
      . Learn about Lung Nodules.
      See more Lung Nodules experts
    • Pleural Effusion
      Dr. Sager is
      Advanced
      . Learn about Pleural Effusion.
      See more Pleural Effusion experts
    View All 8 Advanced Conditions
    • Experienced
    • Acute Interstitial Pneumonia
      Dr. Sager is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Sager is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Allergic Bronchopulmonary Aspergillosis
      Dr. Sager is
      Experienced
      . Learn about Allergic Bronchopulmonary Aspergillosis.
      See more Allergic Bronchopulmonary Aspergillosis experts
    • Aspergillosis
      Dr. Sager is
      Experienced
      . Learn about Aspergillosis.
      See more Aspergillosis experts
    • Asthma
      Dr. Sager is
      Experienced
      . Learn about Asthma.
      See more Asthma experts
    • Asthma in Children
      Dr. Sager is
      Experienced
      . Learn about Asthma in Children.
      See more Asthma in Children experts
    View All 38 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Dr. Jeffrey Sager
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.